Matched unrelated bone marrow transplant for T+ combined immunodeficiency

[1]  Shigeaki Nonoyama,et al.  Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. , 2007, The Journal of allergy and clinical immunology.

[2]  R. Somech,et al.  Bone marrow transplantation for cartilage-hair-hypoplasia , 2006, Bone Marrow Transplantation.

[3]  A. Fischer,et al.  Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. , 2006, The Journal of allergy and clinical immunology.

[4]  Yiping Gu,et al.  Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome. , 2006, The Journal of allergy and clinical immunology.

[5]  T. Morio,et al.  Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team , 2006, Bone Marrow Transplantation.

[6]  L. Notarangelo,et al.  Bone marrow transplantation for severe combined immune deficiency. , 2006, JAMA.

[7]  R. Somech,et al.  Mutation analysis should be performed to rule out gammac deficiency in children with functional severe combined immune deficiency despite apparently normal immunologic tests. , 2005, The Journal of pediatrics.

[8]  B. Williams,et al.  Novel RAG1 Mutation in a Case of Severe Combined Immunodeficiency , 2005, Pediatrics.

[9]  Meng-Yao Lu,et al.  Matched-unrelated-donor bone marrow transplantation for children with leukemia. , 2005, Journal of the Formosan Medical Association = Taiwan yi zhi.

[10]  R. Egeler,et al.  Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation , 2005, Bone Marrow Transplantation.

[11]  C. Roifman.  Studies of patients' thymi aid in the discovery and characterization of immunodeficiency in humans , 2005, Immunological reviews.

[12]  A. Fischer,et al.  Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-center comparative analysis of genoidentical, haploidentical or unrelated donors , 2004, Bone Marrow Transplantation.

[13]  R. Buckley.  Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. , 2004, Annual review of immunology.

[14]  Y. Bertrand,et al.  Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors , 2003, Bone Marrow Transplantation.

[15]  A. Fischer,et al.  Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99 , 2003, The Lancet.

[16]  Todd E DeFor,et al.  Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  J. Hansen,et al.  Trends in transplantation of hematopoietic stem cells from unrelated donors. , 2001, Current opinion in hematology.

[18]  M. Vihinen,et al.  Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency.Defects of the gc‐JAK3 signaling pathway as a model , 2000, Immunological reviews.

[19]  J. Tiercy,et al.  Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor? , 2000, Bone Marrow Transplantation.

[20]  P. Landini,et al.  Artificial nutrition and bone marrow transplantation. , 2000, Haematologica.

[21]  B. Haynes,et al.  Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. , 2000, The New England journal of medicine.

[22]  B. Reid,et al.  Matched unrelated bone marrow transplantation for combined immunodeficiency , 2000, Bone Marrow Transplantation.

[23]  S. Müller,et al.  Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency. , 1999, The Journal of pediatrics.

[24]  J. Roberts,et al.  Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. , 1999, The New England journal of medicine.

[25]  A. Fischer,et al.  Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. , 1998, Blood.

[26]  C. Roifman,et al.  An interleukin-2 receptor gamma chain mutation with normal thymus morphology. , 1997, The Journal of clinical investigation.

[27]  H. Dadi,et al.  Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor , 1997 .

[28]  A. Cohen,et al.  Defective T cell receptor signaling and CD8+ thymic selection in humans lacking Zap-70 kinase , 1994, Cell.

[29]  J. Hansen,et al.  The National Marrow Donor Program , 1993, Transfusion.

[30]  R. Hirschhorn.  Overview of Biochemical Abnormalities and Molecular Genetics of Adenosine Deaminase Deficiency , 1993, Pediatric Research.

[31]  B. Blazar,et al.  Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. , 1992, Blood.

[32]  A. Fischer,et al.  Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report. , 1991, Blood.

[33]  B. Alarcón,et al.  Familial defect in the surface expression of the T-cell receptor-CD3 complex. , 1988, The New England journal of medicine.

[34]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.